nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—Flunisolide—allergic rhinitis	0.124	0.192	CbGbCtD
Conivaptan—CYP3A4—Olopatadine—allergic rhinitis	0.117	0.18	CbGbCtD
Conivaptan—CYP3A4—Montelukast—allergic rhinitis	0.0713	0.11	CbGbCtD
Conivaptan—CYP3A4—Loratadine—allergic rhinitis	0.0713	0.11	CbGbCtD
Conivaptan—CYP3A4—Methylprednisolone—allergic rhinitis	0.0652	0.101	CbGbCtD
Conivaptan—CYP3A4—Triamcinolone—allergic rhinitis	0.0494	0.0764	CbGbCtD
Conivaptan—CYP3A4—Betamethasone—allergic rhinitis	0.0424	0.0656	CbGbCtD
Conivaptan—CYP3A4—Prednisolone—allergic rhinitis	0.0418	0.0647	CbGbCtD
Conivaptan—CYP3A4—Hydrocortisone—allergic rhinitis	0.0396	0.0613	CbGbCtD
Conivaptan—CYP3A4—Dexamethasone—allergic rhinitis	0.0247	0.0381	CbGbCtD
Conivaptan—AVPR1A—respiratory system—allergic rhinitis	0.00621	0.357	CbGeAlD
Conivaptan—AVPR2—respiratory system—allergic rhinitis	0.00514	0.296	CbGeAlD
Conivaptan—AVPR1A—lung—allergic rhinitis	0.0033	0.19	CbGeAlD
Conivaptan—AVPR2—lung—allergic rhinitis	0.00273	0.157	CbGeAlD
Conivaptan—Cardiac disorder—Desloratadine—allergic rhinitis	0.0025	0.00846	CcSEcCtD
Conivaptan—Urinary tract infection—Olopatadine—allergic rhinitis	0.0025	0.00844	CcSEcCtD
Conivaptan—Thirst—Cetirizine—allergic rhinitis	0.00249	0.0084	CcSEcCtD
Conivaptan—Cardiac failure—Cetirizine—allergic rhinitis	0.00242	0.00819	CcSEcCtD
Conivaptan—Mental disorder—Desloratadine—allergic rhinitis	0.00236	0.00799	CcSEcCtD
Conivaptan—Erythema—Desloratadine—allergic rhinitis	0.00235	0.00794	CcSEcCtD
Conivaptan—Dehydration—Cetirizine—allergic rhinitis	0.0022	0.00743	CcSEcCtD
Conivaptan—Thirst—Montelukast—allergic rhinitis	0.00208	0.00704	CcSEcCtD
Conivaptan—Mediastinal disorder—Olopatadine—allergic rhinitis	0.00208	0.00703	CcSEcCtD
Conivaptan—Erythema—Olopatadine—allergic rhinitis	0.00201	0.00679	CcSEcCtD
Conivaptan—Pollakiuria—Loratadine—allergic rhinitis	0.00201	0.00678	CcSEcCtD
Conivaptan—Confusional state—Cyproheptadine—allergic rhinitis	0.00199	0.00672	CcSEcCtD
Conivaptan—Dry mouth—Desloratadine—allergic rhinitis	0.00196	0.00661	CcSEcCtD
Conivaptan—Infection—Desloratadine—allergic rhinitis	0.0019	0.00644	CcSEcCtD
Conivaptan—Pollakiuria—Cetirizine—allergic rhinitis	0.00189	0.00638	CcSEcCtD
Conivaptan—Nervous system disorder—Desloratadine—allergic rhinitis	0.00188	0.00635	CcSEcCtD
Conivaptan—Hypotension—Cyproheptadine—allergic rhinitis	0.00184	0.00623	CcSEcCtD
Conivaptan—Pneumonia—Cetirizine—allergic rhinitis	0.00183	0.00619	CcSEcCtD
Conivaptan—Pneumonia—Flunisolide—allergic rhinitis	0.0018	0.00609	CcSEcCtD
Conivaptan—Insomnia—Cyproheptadine—allergic rhinitis	0.00178	0.00603	CcSEcCtD
Conivaptan—Urinary tract infection—Cetirizine—allergic rhinitis	0.00177	0.00599	CcSEcCtD
Conivaptan—Urinary tract infection—Flunisolide—allergic rhinitis	0.00174	0.00589	CcSEcCtD
Conivaptan—Haematuria—Cetirizine—allergic rhinitis	0.00174	0.00587	CcSEcCtD
Conivaptan—Insomnia—Desloratadine—allergic rhinitis	0.00173	0.00586	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Olopatadine—allergic rhinitis	0.0017	0.00574	CcSEcCtD
Conivaptan—Constipation—Cyproheptadine—allergic rhinitis	0.00169	0.0057	CcSEcCtD
Conivaptan—Dry mouth—Olopatadine—allergic rhinitis	0.00167	0.00565	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Desloratadine—allergic rhinitis	0.00166	0.00559	CcSEcCtD
Conivaptan—Dry mouth—Diphenhydramine—allergic rhinitis	0.00164	0.00553	CcSEcCtD
Conivaptan—Dry mouth—Dimenhydrinate—allergic rhinitis	0.00164	0.00553	CcSEcCtD
Conivaptan—Infection—Olopatadine—allergic rhinitis	0.00163	0.0055	CcSEcCtD
Conivaptan—Feeling abnormal—Cyproheptadine—allergic rhinitis	0.00163	0.00549	CcSEcCtD
Conivaptan—Confusional state—Diphenhydramine—allergic rhinitis	0.00162	0.00547	CcSEcCtD
Conivaptan—Confusional state—Dimenhydrinate—allergic rhinitis	0.00162	0.00547	CcSEcCtD
Conivaptan—Urinary tract disorder—Cetirizine—allergic rhinitis	0.00162	0.00546	CcSEcCtD
Conivaptan—Oedema peripheral—Cetirizine—allergic rhinitis	0.00161	0.00545	CcSEcCtD
Conivaptan—Nervous system disorder—Olopatadine—allergic rhinitis	0.00161	0.00543	CcSEcCtD
Conivaptan—Urethral disorder—Cetirizine—allergic rhinitis	0.0016	0.00542	CcSEcCtD
Conivaptan—Skin disorder—Olopatadine—allergic rhinitis	0.00159	0.00538	CcSEcCtD
Conivaptan—AVPR1A—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	0.00159	0.0396	CbGpPWpGaD
Conivaptan—Oedema peripheral—Flunisolide—allergic rhinitis	0.00158	0.00536	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.00157	0.039	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.00156	0.0387	CbGpPWpGaD
Conivaptan—Pneumonia—Montelukast—allergic rhinitis	0.00154	0.00519	CcSEcCtD
Conivaptan—Infestation—Montelukast—allergic rhinitis	0.00153	0.00516	CcSEcCtD
Conivaptan—Infestation NOS—Montelukast—allergic rhinitis	0.00153	0.00516	CcSEcCtD
Conivaptan—Cardiac disorder—Cetirizine—allergic rhinitis	0.00152	0.00513	CcSEcCtD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.00152	0.0377	CbGpPWpGaD
Conivaptan—Body temperature increased—Desloratadine—allergic rhinitis	0.00152	0.00512	CcSEcCtD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.00151	0.0375	CbGpPWpGaD
Conivaptan—Hypotension—Dimenhydrinate—allergic rhinitis	0.0015	0.00506	CcSEcCtD
Conivaptan—Hypotension—Diphenhydramine—allergic rhinitis	0.0015	0.00506	CcSEcCtD
Conivaptan—Insomnia—Dimenhydrinate—allergic rhinitis	0.00145	0.0049	CcSEcCtD
Conivaptan—Insomnia—Diphenhydramine—allergic rhinitis	0.00145	0.0049	CcSEcCtD
Conivaptan—Mental disorder—Cetirizine—allergic rhinitis	0.00143	0.00484	CcSEcCtD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.00142	0.0354	CbGpPWpGaD
Conivaptan—Gastrointestinal disorder—Olopatadine—allergic rhinitis	0.00142	0.00478	CcSEcCtD
Conivaptan—Pain—Olopatadine—allergic rhinitis	0.0014	0.00474	CcSEcCtD
Conivaptan—Malnutrition—Flunisolide—allergic rhinitis	0.0014	0.00473	CcSEcCtD
Conivaptan—Constipation—Dimenhydrinate—allergic rhinitis	0.00137	0.00464	CcSEcCtD
Conivaptan—Constipation—Diphenhydramine—allergic rhinitis	0.00137	0.00464	CcSEcCtD
Conivaptan—Pruritus—Desloratadine—allergic rhinitis	0.00136	0.00458	CcSEcCtD
Conivaptan—Urinary tract disorder—Montelukast—allergic rhinitis	0.00136	0.00458	CcSEcCtD
Conivaptan—Feeling abnormal—Olopatadine—allergic rhinitis	0.00135	0.00456	CcSEcCtD
Conivaptan—Diarrhoea—Cyproheptadine—allergic rhinitis	0.00135	0.00456	CcSEcCtD
Conivaptan—Urethral disorder—Montelukast—allergic rhinitis	0.00135	0.00454	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00134	0.0334	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00133	0.0332	CbGpPWpGaD
Conivaptan—Candida infection—Triamcinolone—allergic rhinitis	0.00133	0.00448	CcSEcCtD
Conivaptan—Feeling abnormal—Diphenhydramine—allergic rhinitis	0.00132	0.00447	CcSEcCtD
Conivaptan—Feeling abnormal—Dimenhydrinate—allergic rhinitis	0.00132	0.00447	CcSEcCtD
Conivaptan—Diarrhoea—Desloratadine—allergic rhinitis	0.00131	0.00443	CcSEcCtD
Conivaptan—Hypertension—Loratadine—allergic rhinitis	0.00131	0.00442	CcSEcCtD
Conivaptan—Body temperature increased—Olopatadine—allergic rhinitis	0.0013	0.00438	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Loratadine—allergic rhinitis	0.00128	0.00432	CcSEcCtD
Conivaptan—Cardiac disorder—Montelukast—allergic rhinitis	0.00127	0.0043	CcSEcCtD
Conivaptan—Dry mouth—Loratadine—allergic rhinitis	0.00126	0.00426	CcSEcCtD
Conivaptan—Vomiting—Cyproheptadine—allergic rhinitis	0.00125	0.00424	CcSEcCtD
Conivaptan—Mediastinal disorder—Montelukast—allergic rhinitis	0.00124	0.00418	CcSEcCtD
Conivaptan—Headache—Cyproheptadine—allergic rhinitis	0.00124	0.00418	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.00123	0.0306	CbGpPWpGaD
Conivaptan—Hypertension—Cetirizine—allergic rhinitis	0.00123	0.00416	CcSEcCtD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.00122	0.0304	CbGpPWpGaD
Conivaptan—Vomiting—Desloratadine—allergic rhinitis	0.00122	0.00412	CcSEcCtD
Conivaptan—Nervous system disorder—Loratadine—allergic rhinitis	0.00121	0.00409	CcSEcCtD
Conivaptan—Hypertension—Flunisolide—allergic rhinitis	0.00121	0.00409	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Cetirizine—allergic rhinitis	0.0012	0.00407	CcSEcCtD
Conivaptan—Mental disorder—Montelukast—allergic rhinitis	0.0012	0.00406	CcSEcCtD
Conivaptan—Headache—Desloratadine—allergic rhinitis	0.0012	0.00406	CcSEcCtD
Conivaptan—Skin disorder—Loratadine—allergic rhinitis	0.0012	0.00405	CcSEcCtD
Conivaptan—Dry mouth—Cetirizine—allergic rhinitis	0.00119	0.00401	CcSEcCtD
Conivaptan—Confusional state—Cetirizine—allergic rhinitis	0.00117	0.00396	CcSEcCtD
Conivaptan—Nausea—Cyproheptadine—allergic rhinitis	0.00117	0.00396	CcSEcCtD
Conivaptan—Pruritus—Olopatadine—allergic rhinitis	0.00116	0.00392	CcSEcCtD
Conivaptan—Infection—Cetirizine—allergic rhinitis	0.00115	0.0039	CcSEcCtD
Conivaptan—Hypotension—Loratadine—allergic rhinitis	0.00115	0.0039	CcSEcCtD
Conivaptan—Nervous system disorder—Cetirizine—allergic rhinitis	0.00114	0.00385	CcSEcCtD
Conivaptan—Nausea—Desloratadine—allergic rhinitis	0.00114	0.00385	CcSEcCtD
Conivaptan—Infection—Flunisolide—allergic rhinitis	0.00114	0.00384	CcSEcCtD
Conivaptan—Skin disorder—Cetirizine—allergic rhinitis	0.00113	0.00382	CcSEcCtD
Conivaptan—Diarrhoea—Olopatadine—allergic rhinitis	0.00112	0.00379	CcSEcCtD
Conivaptan—Insomnia—Loratadine—allergic rhinitis	0.00112	0.00378	CcSEcCtD
Conivaptan—AVPR1A—G alpha (q) signalling events—TAC1—allergic rhinitis	0.00112	0.0278	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.0011	0.0274	CbGpPWpGaD
Conivaptan—Diarrhoea—Diphenhydramine—allergic rhinitis	0.0011	0.00371	CcSEcCtD
Conivaptan—Diarrhoea—Dimenhydrinate—allergic rhinitis	0.0011	0.00371	CcSEcCtD
Conivaptan—Cardiac failure—Hydrocortisone—allergic rhinitis	0.0011	0.00371	CcSEcCtD
Conivaptan—AVPR2—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.0011	0.0272	CbGpPWpGaD
Conivaptan—Hypotension—Cetirizine—allergic rhinitis	0.00109	0.00367	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Loratadine—allergic rhinitis	0.00107	0.0036	CcSEcCtD
Conivaptan—Pain—Loratadine—allergic rhinitis	0.00106	0.00357	CcSEcCtD
Conivaptan—Constipation—Loratadine—allergic rhinitis	0.00106	0.00357	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00105	0.0262	CbGpPWpGaD
Conivaptan—Insomnia—Cetirizine—allergic rhinitis	0.00105	0.00355	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00105	0.026	CbGpPWpGaD
Conivaptan—Vomiting—Olopatadine—allergic rhinitis	0.00104	0.00352	CcSEcCtD
Conivaptan—Insomnia—Flunisolide—allergic rhinitis	0.00103	0.00349	CcSEcCtD
Conivaptan—Cardiac failure—Methylprednisolone—allergic rhinitis	0.00103	0.00348	CcSEcCtD
Conivaptan—Headache—Olopatadine—allergic rhinitis	0.00103	0.00347	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00102	0.0254	CbGpPWpGaD
Conivaptan—Vomiting—Diphenhydramine—allergic rhinitis	0.00102	0.00345	CcSEcCtD
Conivaptan—Vomiting—Dimenhydrinate—allergic rhinitis	0.00102	0.00345	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.00102	0.0253	CbGpPWpGaD
Conivaptan—Feeling abnormal—Loratadine—allergic rhinitis	0.00102	0.00344	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00102	0.0253	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.00101	0.0251	CbGpPWpGaD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Montelukast—allergic rhinitis	0.00101	0.00341	CcSEcCtD
Conivaptan—Headache—Dimenhydrinate—allergic rhinitis	0.001	0.0034	CcSEcCtD
Conivaptan—Headache—Diphenhydramine—allergic rhinitis	0.001	0.0034	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Cetirizine—allergic rhinitis	0.001	0.00339	CcSEcCtD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.000999	0.0248	CbGpPWpGaD
Conivaptan—Constipation—Cetirizine—allergic rhinitis	0.000994	0.00336	CcSEcCtD
Conivaptan—Pain—Cetirizine—allergic rhinitis	0.000994	0.00336	CcSEcCtD
Conivaptan—Pain—Flunisolide—allergic rhinitis	0.000977	0.0033	CcSEcCtD
Conivaptan—Constipation—Flunisolide—allergic rhinitis	0.000977	0.0033	CcSEcCtD
Conivaptan—Body temperature increased—Loratadine—allergic rhinitis	0.000977	0.0033	CcSEcCtD
Conivaptan—Hypokalaemia—Hydrocortisone—allergic rhinitis	0.000975	0.00329	CcSEcCtD
Conivaptan—Nausea—Olopatadine—allergic rhinitis	0.000974	0.00329	CcSEcCtD
Conivaptan—Infection—Montelukast—allergic rhinitis	0.000968	0.00327	CcSEcCtD
Conivaptan—Feeling abnormal—Cetirizine—allergic rhinitis	0.000958	0.00324	CcSEcCtD
Conivaptan—Nervous system disorder—Montelukast—allergic rhinitis	0.000956	0.00323	CcSEcCtD
Conivaptan—Nausea—Dimenhydrinate—allergic rhinitis	0.000953	0.00322	CcSEcCtD
Conivaptan—Nausea—Diphenhydramine—allergic rhinitis	0.000953	0.00322	CcSEcCtD
Conivaptan—Skin disorder—Montelukast—allergic rhinitis	0.000947	0.0032	CcSEcCtD
Conivaptan—Feeling abnormal—Flunisolide—allergic rhinitis	0.000942	0.00318	CcSEcCtD
Conivaptan—Cardiac failure—Dexamethasone—allergic rhinitis	0.000938	0.00317	CcSEcCtD
Conivaptan—Cardiac failure—Betamethasone—allergic rhinitis	0.000938	0.00317	CcSEcCtD
Conivaptan—Body temperature increased—Cetirizine—allergic rhinitis	0.000919	0.00311	CcSEcCtD
Conivaptan—Body temperature increased—Flunisolide—allergic rhinitis	0.000904	0.00305	CcSEcCtD
Conivaptan—Insomnia—Montelukast—allergic rhinitis	0.000882	0.00298	CcSEcCtD
Conivaptan—Diarrhoea—Loratadine—allergic rhinitis	0.000845	0.00286	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.000842	0.00284	CcSEcCtD
Conivaptan—Pain—Montelukast—allergic rhinitis	0.000834	0.00282	CcSEcCtD
Conivaptan—Hypokalaemia—Betamethasone—allergic rhinitis	0.000833	0.00281	CcSEcCtD
Conivaptan—Hypokalaemia—Dexamethasone—allergic rhinitis	0.000833	0.00281	CcSEcCtD
Conivaptan—Infestation NOS—Hydrocortisone—allergic rhinitis	0.000825	0.00279	CcSEcCtD
Conivaptan—Infestation—Hydrocortisone—allergic rhinitis	0.000825	0.00279	CcSEcCtD
Conivaptan—Pruritus—Cetirizine—allergic rhinitis	0.000822	0.00278	CcSEcCtD
Conivaptan—Pruritus—Flunisolide—allergic rhinitis	0.000809	0.00273	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000803	0.02	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000797	0.0198	CbGpPWpGaD
Conivaptan—Diarrhoea—Cetirizine—allergic rhinitis	0.000795	0.00269	CcSEcCtD
Conivaptan—Vomiting—Loratadine—allergic rhinitis	0.000786	0.00265	CcSEcCtD
Conivaptan—Diarrhoea—Flunisolide—allergic rhinitis	0.000782	0.00264	CcSEcCtD
Conivaptan—Infestation NOS—Methylprednisolone—allergic rhinitis	0.000775	0.00262	CcSEcCtD
Conivaptan—Infestation—Methylprednisolone—allergic rhinitis	0.000775	0.00262	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—CCL11—allergic rhinitis	0.000775	0.0193	CbGpPWpGaD
Conivaptan—Headache—Loratadine—allergic rhinitis	0.000774	0.00262	CcSEcCtD
Conivaptan—Body temperature increased—Montelukast—allergic rhinitis	0.000771	0.0026	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—CCL11—allergic rhinitis	0.00077	0.0191	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.00074	0.0184	CbGpPWpGaD
Conivaptan—Vomiting—Cetirizine—allergic rhinitis	0.000739	0.0025	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000734	0.0183	CbGpPWpGaD
Conivaptan—Nausea—Loratadine—allergic rhinitis	0.000734	0.00248	CcSEcCtD
Conivaptan—Headache—Cetirizine—allergic rhinitis	0.000728	0.00246	CcSEcCtD
Conivaptan—Vomiting—Flunisolide—allergic rhinitis	0.000727	0.00246	CcSEcCtD
Conivaptan—Headache—Flunisolide—allergic rhinitis	0.000716	0.00242	CcSEcCtD
Conivaptan—Hyperglycaemia—Betamethasone—allergic rhinitis	0.000713	0.00241	CcSEcCtD
Conivaptan—Hyperglycaemia—Dexamethasone—allergic rhinitis	0.000713	0.00241	CcSEcCtD
Conivaptan—Nausea—Cetirizine—allergic rhinitis	0.00069	0.00233	CcSEcCtD
Conivaptan—Pruritus—Montelukast—allergic rhinitis	0.00069	0.00233	CcSEcCtD
Conivaptan—Nausea—Flunisolide—allergic rhinitis	0.000679	0.00229	CcSEcCtD
Conivaptan—Diarrhoea—Montelukast—allergic rhinitis	0.000667	0.00225	CcSEcCtD
Conivaptan—Erythema—Prednisolone—allergic rhinitis	0.00066	0.00223	CcSEcCtD
Conivaptan—Mental disorder—Hydrocortisone—allergic rhinitis	0.000649	0.00219	CcSEcCtD
Conivaptan—Cardiac disorder—Methylprednisolone—allergic rhinitis	0.000646	0.00218	CcSEcCtD
Conivaptan—Malnutrition—Hydrocortisone—allergic rhinitis	0.000645	0.00218	CcSEcCtD
Conivaptan—Erythema—Hydrocortisone—allergic rhinitis	0.000645	0.00218	CcSEcCtD
Conivaptan—Angiopathy—Methylprednisolone—allergic rhinitis	0.000632	0.00213	CcSEcCtD
Conivaptan—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000627	0.00212	CcSEcCtD
Conivaptan—Vomiting—Montelukast—allergic rhinitis	0.00062	0.00209	CcSEcCtD
Conivaptan—Headache—Montelukast—allergic rhinitis	0.000611	0.00206	CcSEcCtD
Conivaptan—Mental disorder—Methylprednisolone—allergic rhinitis	0.00061	0.00206	CcSEcCtD
Conivaptan—Erythema—Triamcinolone—allergic rhinitis	0.000607	0.00205	CcSEcCtD
Conivaptan—Erythema—Methylprednisolone—allergic rhinitis	0.000606	0.00205	CcSEcCtD
Conivaptan—Malnutrition—Methylprednisolone—allergic rhinitis	0.000606	0.00205	CcSEcCtD
Conivaptan—Nausea—Montelukast—allergic rhinitis	0.000579	0.00196	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000578	0.0144	CbGpPWpGaD
Conivaptan—Angiopathy—Dexamethasone—allergic rhinitis	0.000574	0.00194	CcSEcCtD
Conivaptan—Angiopathy—Betamethasone—allergic rhinitis	0.000574	0.00194	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000574	0.0143	CbGpPWpGaD
Conivaptan—Hypertension—Prednisolone—allergic rhinitis	0.00057	0.00193	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—TAC1—allergic rhinitis	0.000563	0.014	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—TAC1—allergic rhinitis	0.000559	0.0139	CbGpPWpGaD
Conivaptan—Hypertension—Hydrocortisone—allergic rhinitis	0.000557	0.00188	CcSEcCtD
Conivaptan—Erythema—Dexamethasone—allergic rhinitis	0.000551	0.00186	CcSEcCtD
Conivaptan—Erythema—Betamethasone—allergic rhinitis	0.000551	0.00186	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000545	0.00184	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000525	0.0131	CbGpPWpGaD
Conivaptan—Hypertension—Triamcinolone—allergic rhinitis	0.000524	0.00177	CcSEcCtD
Conivaptan—Hypertension—Methylprednisolone—allergic rhinitis	0.000523	0.00177	CcSEcCtD
Conivaptan—Infection—Hydrocortisone—allergic rhinitis	0.000523	0.00177	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000521	0.013	CbGpPWpGaD
Conivaptan—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.000516	0.00174	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000512	0.00173	CcSEcCtD
Conivaptan—Skin disorder—Hydrocortisone—allergic rhinitis	0.000511	0.00173	CcSEcCtD
Conivaptan—Dry mouth—Triamcinolone—allergic rhinitis	0.000506	0.00171	CcSEcCtD
Conivaptan—Confusional state—Methylprednisolone—allergic rhinitis	0.000499	0.00169	CcSEcCtD
Conivaptan—Infection—Triamcinolone—allergic rhinitis	0.000492	0.00166	CcSEcCtD
Conivaptan—Hypotension—Hydrocortisone—allergic rhinitis	0.000492	0.00166	CcSEcCtD
Conivaptan—Infection—Methylprednisolone—allergic rhinitis	0.000491	0.00166	CcSEcCtD
Conivaptan—Insomnia—Prednisolone—allergic rhinitis	0.000487	0.00165	CcSEcCtD
Conivaptan—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000485	0.00164	CcSEcCtD
Conivaptan—Skin disorder—Methylprednisolone—allergic rhinitis	0.00048	0.00162	CcSEcCtD
Conivaptan—Insomnia—Hydrocortisone—allergic rhinitis	0.000476	0.00161	CcSEcCtD
Conivaptan—Hypertension—Dexamethasone—allergic rhinitis	0.000476	0.00161	CcSEcCtD
Conivaptan—Hypertension—Betamethasone—allergic rhinitis	0.000476	0.00161	CcSEcCtD
Conivaptan—Hypotension—Methylprednisolone—allergic rhinitis	0.000462	0.00156	CcSEcCtD
Conivaptan—Pain—Prednisolone—allergic rhinitis	0.000461	0.00156	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000454	0.00154	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000454	0.0113	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.00045	0.0112	CbGpPWpGaD
Conivaptan—Pain—Hydrocortisone—allergic rhinitis	0.00045	0.00152	CcSEcCtD
Conivaptan—Insomnia—Triamcinolone—allergic rhinitis	0.000448	0.00151	CcSEcCtD
Conivaptan—Insomnia—Methylprednisolone—allergic rhinitis	0.000447	0.00151	CcSEcCtD
Conivaptan—Infection—Dexamethasone—allergic rhinitis	0.000447	0.00151	CcSEcCtD
Conivaptan—Infection—Betamethasone—allergic rhinitis	0.000447	0.00151	CcSEcCtD
Conivaptan—Feeling abnormal—Prednisolone—allergic rhinitis	0.000444	0.0015	CcSEcCtD
Conivaptan—Nervous system disorder—Dexamethasone—allergic rhinitis	0.000441	0.00149	CcSEcCtD
Conivaptan—Nervous system disorder—Betamethasone—allergic rhinitis	0.000441	0.00149	CcSEcCtD
Conivaptan—Feeling abnormal—Hydrocortisone—allergic rhinitis	0.000434	0.00147	CcSEcCtD
Conivaptan—Pain—Triamcinolone—allergic rhinitis	0.000424	0.00143	CcSEcCtD
Conivaptan—Hypotension—Betamethasone—allergic rhinitis	0.00042	0.00142	CcSEcCtD
Conivaptan—Hypotension—Dexamethasone—allergic rhinitis	0.00042	0.00142	CcSEcCtD
Conivaptan—Body temperature increased—Hydrocortisone—allergic rhinitis	0.000416	0.00141	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000412	0.0102	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000409	0.0102	CbGpPWpGaD
Conivaptan—Feeling abnormal—Triamcinolone—allergic rhinitis	0.000408	0.00138	CcSEcCtD
Conivaptan—Feeling abnormal—Methylprednisolone—allergic rhinitis	0.000408	0.00138	CcSEcCtD
Conivaptan—Insomnia—Betamethasone—allergic rhinitis	0.000407	0.00137	CcSEcCtD
Conivaptan—Insomnia—Dexamethasone—allergic rhinitis	0.000407	0.00137	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—CCL11—allergic rhinitis	0.000398	0.00989	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCL11—allergic rhinitis	0.000395	0.00982	CbGpPWpGaD
Conivaptan—Body temperature increased—Triamcinolone—allergic rhinitis	0.000392	0.00132	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.000388	0.00131	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.000388	0.00131	CcSEcCtD
Conivaptan—Pain—Betamethasone—allergic rhinitis	0.000385	0.0013	CcSEcCtD
Conivaptan—Pain—Dexamethasone—allergic rhinitis	0.000385	0.0013	CcSEcCtD
Conivaptan—Pruritus—Hydrocortisone—allergic rhinitis	0.000372	0.00126	CcSEcCtD
Conivaptan—Feeling abnormal—Dexamethasone—allergic rhinitis	0.000371	0.00125	CcSEcCtD
Conivaptan—Feeling abnormal—Betamethasone—allergic rhinitis	0.000371	0.00125	CcSEcCtD
Conivaptan—Diarrhoea—Hydrocortisone—allergic rhinitis	0.00036	0.00122	CcSEcCtD
Conivaptan—Body temperature increased—Dexamethasone—allergic rhinitis	0.000356	0.0012	CcSEcCtD
Conivaptan—Body temperature increased—Betamethasone—allergic rhinitis	0.000356	0.0012	CcSEcCtD
Conivaptan—Pruritus—Triamcinolone—allergic rhinitis	0.000351	0.00118	CcSEcCtD
Conivaptan—Pruritus—Methylprednisolone—allergic rhinitis	0.00035	0.00118	CcSEcCtD
Conivaptan—Diarrhoea—Methylprednisolone—allergic rhinitis	0.000338	0.00114	CcSEcCtD
Conivaptan—Headache—Prednisolone—allergic rhinitis	0.000338	0.00114	CcSEcCtD
Conivaptan—Vomiting—Hydrocortisone—allergic rhinitis	0.000335	0.00113	CcSEcCtD
Conivaptan—Headache—Hydrocortisone—allergic rhinitis	0.00033	0.00111	CcSEcCtD
Conivaptan—Nausea—Prednisolone—allergic rhinitis	0.00032	0.00108	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—TAC1—allergic rhinitis	0.000318	0.00791	CbGpPWpGaD
Conivaptan—Pruritus—Betamethasone—allergic rhinitis	0.000318	0.00108	CcSEcCtD
Conivaptan—Pruritus—Dexamethasone—allergic rhinitis	0.000318	0.00108	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—TAC1—allergic rhinitis	0.000316	0.00786	CbGpPWpGaD
Conivaptan—Vomiting—Triamcinolone—allergic rhinitis	0.000315	0.00106	CcSEcCtD
Conivaptan—Vomiting—Methylprednisolone—allergic rhinitis	0.000314	0.00106	CcSEcCtD
Conivaptan—Nausea—Hydrocortisone—allergic rhinitis	0.000313	0.00106	CcSEcCtD
Conivaptan—Headache—Triamcinolone—allergic rhinitis	0.000311	0.00105	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—PTGDR2—allergic rhinitis	0.00031	0.00771	CbGpPWpGaD
Conivaptan—Headache—Methylprednisolone—allergic rhinitis	0.00031	0.00105	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—PTGDR2—allergic rhinitis	0.000308	0.00766	CbGpPWpGaD
Conivaptan—Diarrhoea—Dexamethasone—allergic rhinitis	0.000308	0.00104	CcSEcCtD
Conivaptan—Diarrhoea—Betamethasone—allergic rhinitis	0.000308	0.00104	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—IL5—allergic rhinitis	0.000296	0.00736	CbGpPWpGaD
Conivaptan—Nausea—Triamcinolone—allergic rhinitis	0.000294	0.000995	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—IL5—allergic rhinitis	0.000294	0.00731	CbGpPWpGaD
Conivaptan—Nausea—Methylprednisolone—allergic rhinitis	0.000294	0.000993	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—TAC1—allergic rhinitis	0.000289	0.00719	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—TAC1—allergic rhinitis	0.000287	0.00714	CbGpPWpGaD
Conivaptan—Vomiting—Dexamethasone—allergic rhinitis	0.000286	0.000966	CcSEcCtD
Conivaptan—Vomiting—Betamethasone—allergic rhinitis	0.000286	0.000966	CcSEcCtD
Conivaptan—Headache—Dexamethasone—allergic rhinitis	0.000282	0.000952	CcSEcCtD
Conivaptan—Headache—Betamethasone—allergic rhinitis	0.000282	0.000952	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—IL5—allergic rhinitis	0.000269	0.00668	CbGpPWpGaD
Conivaptan—Nausea—Dexamethasone—allergic rhinitis	0.000267	0.000903	CcSEcCtD
Conivaptan—Nausea—Betamethasone—allergic rhinitis	0.000267	0.000903	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—IL5—allergic rhinitis	0.000267	0.00663	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000243	0.00605	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000242	0.00601	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL11—allergic rhinitis	0.000235	0.00584	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL11—allergic rhinitis	0.000233	0.0058	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TAC1—allergic rhinitis	0.000171	0.00425	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TAC1—allergic rhinitis	0.00017	0.00422	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL5—allergic rhinitis	0.000159	0.00395	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL5—allergic rhinitis	0.000158	0.00392	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SMAD3—allergic rhinitis	0.000112	0.00278	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SMAD3—allergic rhinitis	0.000111	0.00276	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NFKB1—allergic rhinitis	5.68e-05	0.00141	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NFKB1—allergic rhinitis	5.64e-05	0.0014	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TGFB1—allergic rhinitis	4.73e-05	0.00118	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TGFB1—allergic rhinitis	4.7e-05	0.00117	CbGpPWpGaD
